PharmaCord: Driving Results through a Patient-Centric Approach

Among the oodles of buzzwords that are currently pervading the world of healthcare, patient-centricity is one that is engendering a real shift in focus for the pharma and life sciences industry. Putting the patient first and adopting a patient-centric approach is considered to be the essence of high-quality healthcare and long-term industry success by most experts. This is propelling pharma companies to re-evaluate their offerings and ensure that the products and services they provide align with the needs of their customers. In regard to this, the pharma sector is slowly turning to patient support programs (PSPs) and services to help drive clinical and commercial success. With a prime objective to address the common challenges that the pharma/biopharma stakeholders encounter, PharmaCord, an independently owned healthcare services company, has built an innovative technology platform—CORscend. Powered by AI, the platform transcends traditional hub services by overcoming the predicaments related to inefficient patient support processes, siloed and rigid systems, and lack of actionable data; thereby enabling better patient experiences and commercial outcomes. “Our proprietary platform links reimbursement services, patient-centric pharmacy, care coordination, clinical services, and patient assistance programs to enhance the therapy experience,” expresses Nitin Sahney, founder and CEO, PharmaCord.

One of the primary issues seen in the life sciences industry concerns multiple complex medications. Every medication developed has different characteristics based on the disease state, the size of the patient population, and the product’s route of administration. “And, in order to design the right patient support program for the medication, it is necessary to understand the optimal path of patients undergoing a particular therapy,” says Sahney. For this, PharmaCord has developed a unique approach called 3-D, where PharmaCord’s team engages with clients in three phases—discovery, development, and deployment. “This approach helps us understand the many different characteristics of the product in designing a PSP that helps provide patients with excellent experiences,” adds Sahney.